Celgene Corporation

Global biopharmaceutical company

Based in NJ

🤖

AI Overview

With $450K in lobbying spend across 9 quarterly filings, Celgene Corporation is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2019.

$450K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$200K
2019	$250K

Issues Lobbied

Health Issues Medicare/Medicaid

Lobbying Firms

Splitoak Strategies LLC

Lobbyists

Sarah Egge Amy Jensen

Government Agencies Targeted

These are the government entities that Celgene Corporation disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Executive Office of the President (EOP)Office of Management & Budget (OMB)White House OfficeCenters For Medicare and Medicaid Services (CMS)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

HR 2212/S 974 - CREATES Act; HR 2051 - FAST Generics Act; Medicare Reimbursement for Transformative Therapies

HR 2212/S 974 - CREATES Act; HR 2051 - FAST Generics Act; Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies

HR 2212/S 974 - CREATES Act; HR 2051 - FAST Generics Act; Medicare Coverage and Reimbursement for Transformative Therapies

S. 340/H.R. 965 CREATES Act